Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comparative analysis of fusion tags used to functionalize recombinant antibodies.

Veggiani G, Giabbai B, Semrau MS, Medagli B, Riccio V, Bajc G, Storici P, de Marco A.

Protein Expr Purif. 2020 Feb;166:105505. doi: 10.1016/j.pep.2019.105505. Epub 2019 Sep 26.

PMID:
31563543
2.

The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency.

Manczyk N, Veggiani G, Teyra J, Strilchuk AW, Sidhu SS, Sicheri F.

Sci Rep. 2019 Mar 11;9(1):4119. doi: 10.1038/s41598-019-40815-z.

3.

Emerging drug development technologies targeting ubiquitination for cancer therapeutics.

Veggiani G, Gerpe MCR, Sidhu SS, Zhang W.

Pharmacol Ther. 2019 Jul;199:139-154. doi: 10.1016/j.pharmthera.2019.03.003. Epub 2019 Mar 7. Review.

PMID:
30851297
4.

Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif.

Manczyk N, Veggiani G, Gish GD, Yates BP, Ernst A, Sidhu SS, Sicheri F.

Protein Sci. 2019 May;28(5):848-856. doi: 10.1002/pro.3593. Epub 2019 Mar 12.

PMID:
30793400
5.

Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.

Veggiani G, Huang H, Yates BP, Tong J, Kaneko T, Joshi R, Li SSC, Moran MF, Gish G, Sidhu SS.

Protein Sci. 2019 Feb;28(2):403-413. doi: 10.1002/pro.3551. Epub 2018 Dec 24.

PMID:
30431205
6.

Whole-cell biopanning with a synthetic phage display library of nanobodies enabled the recovery of follicle-stimulating hormone receptor inhibitors.

Crepin R, Veggiani G, Djender S, Beugnet A, Planeix F, Pichon C, Moutel S, Amigorena S, Perez F, Ghinea N, de Marco A.

Biochem Biophys Res Commun. 2017 Dec 2;493(4):1567-1572. doi: 10.1016/j.bbrc.2017.10.036. Epub 2017 Oct 7.

PMID:
29017919
7.

Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha-helical ubiquitin interacting motif.

Manczyk N, Yates BP, Veggiani G, Ernst A, Sicheri F, Sidhu SS.

Protein Sci. 2017 May;26(5):1060-1069. doi: 10.1002/pro.3155. Epub 2017 Mar 24.

8.

Programmable polyproteams built using twin peptide superglues.

Veggiani G, Nakamura T, Brenner MD, Gayet RV, Yan J, Robinson CV, Howarth M.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1202-7. doi: 10.1073/pnas.1519214113. Epub 2016 Jan 19.

9.

Superglue from bacteria: unbreakable bridges for protein nanotechnology.

Veggiani G, Zakeri B, Howarth M.

Trends Biotechnol. 2014 Oct;32(10):506-12. doi: 10.1016/j.tibtech.2014.08.001. Epub 2014 Aug 26. Review.

10.

SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly.

Fairhead M, Veggiani G, Lever M, Yan J, Mesner D, Robinson CV, Dushek O, van der Merwe PA, Howarth M.

J Am Chem Soc. 2014 Sep 3;136(35):12355-63. doi: 10.1021/ja505584f. Epub 2014 Aug 21.

11.

SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture.

Fierer JO, Veggiani G, Howarth M.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1176-81. doi: 10.1073/pnas.1315776111. Epub 2014 Mar 17.

12.

Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells.

Jain J, Veggiani G, Howarth M.

Cancer Res. 2013 Apr 1;73(7):2310-21. doi: 10.1158/0008-5472.CAN-12-2956. Epub 2013 Feb 1.

13.

Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1.

Veggiani G, Ossolengo G, Aliprandi M, Cavallaro U, de Marco A.

Biochem Biophys Res Commun. 2011 May 20;408(4):692-6. doi: 10.1016/j.bbrc.2011.04.090. Epub 2011 Apr 24.

PMID:
21539817
14.

Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase.

Veggiani G, de Marco A.

Protein Expr Purif. 2011 Sep;79(1):111-4. doi: 10.1016/j.pep.2011.03.005. Epub 2011 Mar 21.

PMID:
21421053
15.

Solid-phase preparation of protein complexes.

Pengo P, Veggiani G, Rattanamanee K, Gallotta A, Beneduce L, Fassina G.

J Mol Recognit. 2010 Nov-Dec;23(6):551-8. doi: 10.1002/jmr.1095.

PMID:
21038355
16.

Combinatorial semisynthesis of biomarker-IgM complexes.

Veggiani G, Zuin J, Beneduce L, Gallotta A, Pengo P, Fassina G.

J Biomol Screen. 2010 Dec;15(10):1274-80. doi: 10.1177/1087057110378623. Epub 2010 Oct 11.

PMID:
20938047
17.

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.

Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Toth R, Cerin D, Frecer V, Meo S, Gion M, Fassina G, Beneduce L.

Clin Chem Lab Med. 2010 Feb;48(2):217-23. doi: 10.1515/CCLM.2010.044.

PMID:
20001440

Supplemental Content

Loading ...
Support Center